US Stock MarketDetailed Quotes
ALLR Allarity Therapeutics
- 0.1829
- +0.0062+3.51%
Close Aug 23 16:00 ET
- 0.1802
- -0.0027-1.48%
Post 20:01 ET
7.75MMarket Cap-499P/E (TTM)
0.2000High0.1755Low2.80MVolume0.1800Open0.1767Pre Close533.26KTurnover6.61%Turnover Ratio0.00P/E (Static)42.38MShares38.200052wk High0.39P/B7.75MFloat Cap0.138052wk Low--Dividend TTM42.38MShs Float509600.0000Historical High--Div YieldTTM13.87%Amplitude0.1380Historical Low0.1900Avg Price1Lot Size
Allarity Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -18.89%3.37M | 15.59%4.24M | 1.40%17.13M | 53.14%4.88M | -2.98%4.43M | -14.17%4.16M | -14.74%3.67M | -36.39%16.89M | -79.76%3.19M | 14.80%4.56M |
| Selling and administrative expenses | -24.19%2.31M | -7.63%2.07M | 0.64%10.03M | 0.49%2.26M | 59.05%2.48M | -3.02%3.05M | -25.62%2.24M | -19.40%9.96M | -63.91%2.25M | -40.51%1.56M |
| -General and administrative expense | -24.19%2.31M | -7.63%2.07M | 0.64%10.03M | 0.49%2.26M | 59.05%2.48M | -3.02%3.05M | -25.62%2.24M | -19.40%9.96M | -63.91%2.25M | -40.51%1.56M |
| Research and development costs | -4.25%1.06M | 52.07%2.17M | 2.50%7.1M | 178.75%2.62M | -35.15%1.95M | -34.85%1.11M | 10.71%1.43M | -51.18%6.93M | -90.12%941K | 121.70%3M |
| Operating profit | 18.89%-3.37M | -15.59%-4.24M | -1.40%-17.13M | -53.14%-4.88M | 2.98%-4.43M | 14.17%-4.16M | 14.74%-3.67M | 36.39%-16.89M | 79.76%-3.19M | -14.80%-4.56M |
| Net non-operating interest income expense | -168.35%-373K | -15.91%-102K | -146.63%-476K | -116.19%-227K | -4.76%-22K | -396.43%-139K | -125.64%-88K | 90.29%-193K | 92.26%-105K | -2,200.00%-21K |
| Non-operating interest income | 1,666.67%53K | --0 | -26.67%22K | -72.73%3K | -14.29%12K | -40.00%3K | --4K | --30K | --11K | -50.00%14K |
| Non-operating interest expense | 200.00%426K | 10.87%102K | 123.32%498K | 98.28%230K | -2.86%34K | 330.30%142K | 135.90%92K | -65.16%223K | -71.14%116K | 29.63%35K |
| Other net income (expense) | 10.44%2.12M | 22.52%495K | 1,271.46%5.79M | 2,211.33%3.47M | 100.22%1K | 936.24%1.92M | 1,088.24%404K | -124.36%-494K | -52.53%150K | -116.90%-449K |
| Gain on sale of security | 10.44%2.12M | 22.52%495K | -60.38%6.38M | 9.26%4.06M | 100.22%1K | 235.38%1.92M | -96.70%404K | 975.28%16.1M | 2,084.71%3.71M | -127.10%-449K |
| Special income (charges) | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -1,750.85%-16.59M | -844.05%-3.56M | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --17.57M | --3.56M | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --800K | --0 | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 77.11%1.78M | --0 | --0 |
| Other non- operating income (expenses) | ---- | ---- | ---591K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 31.55%-1.63M | -14.77%-3.85M | 32.77%-11.82M | 47.82%-1.64M | 11.63%-4.45M | 53.32%-2.38M | 22.17%-3.35M | 33.70%-17.58M | 81.28%-3.14M | -282.37%-5.03M |
| Income tax | 0 | -4K | 105.46%83K | 127.39%83K | 0 | 0 | 0 | -1,243.61%-1.52M | -965.71%-303K | -85.71%5K |
| Net income | 31.55%-1.63M | -14.65%-3.84M | 25.89%-11.9M | 39.32%-1.72M | 11.71%-4.45M | 53.36%-2.38M | -8.83%-3.35M | 39.74%-16.06M | 83.12%-2.84M | -272.83%-5.04M |
| Net income continuous Operations | 31.55%-1.63M | -14.65%-3.84M | 25.89%-11.9M | 39.32%-1.72M | 11.71%-4.45M | 53.36%-2.38M | -8.83%-3.35M | 39.74%-16.06M | 83.12%-2.84M | -272.83%-5.04M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 31.55%-1.63M | -14.65%-3.84M | 25.89%-11.9M | 39.32%-1.72M | 11.71%-4.45M | 53.36%-2.38M | -8.83%-3.35M | 39.74%-16.06M | 83.12%-2.84M | -272.83%-5.04M |
| Preferred stock dividends | -99.04%71K | 825.00%37K | 70.54%8.52M | 0 | -32.87%1.11M | 437.84%7.41M | -99.75%4K | 4.99M | 264K | 1.65M |
| Other preferred stock dividends | -31K | 0 | ||||||||
| Net income attributable to common stockholders | 82.95%-1.67M | -15.61%-3.88M | 3.02%-20.42M | 44.49%-1.72M | 16.92%-5.55M | -51.02%-9.79M | 27.86%-3.36M | 21.00%-21.05M | 81.55%-3.1M | -394.67%-6.68M |
| Basic earnings per share | 99.98%-0.11 | 99.02%-22.14 | 86.73%-205.2 | 96.25%-5.8503 | 91.73%-44.8 | 8.59%-525.53 | -403.42%-2.26K | 53.86%-1.55K | 90.61%-156.099 | -304.66%-541.6024 |
| Diluted earnings per share | 99.98%-0.11 | 99.02%-22.14 | 86.73%-205.2 | 96.25%-5.8503 | 91.73%-44.8 | 8.59%-525.53 | -403.42%-2.26K | 53.86%-1.55K | 90.61%-156.099 | -304.66%-541.6024 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg